Swedish Growth Companies With High Insider Ownership To Watch In July 2024
In This Article:
As global markets experience fluctuations, with indices like the Russell 2000 showcasing notable gains, the Swedish market remains a point of interest for investors looking for growth opportunities. High insider ownership in Swedish companies often signals strong confidence from those who know the business best, making such stocks particularly intriguing in the current economic landscape.
Top 10 Growth Companies With High Insider Ownership In Sweden
| Name | Insider Ownership | Earnings Growth |
| CTT Systems (OM:CTT) | 16.9% | 21.6% |
| Biovica International (OM:BIOVIC B) | 18.5% | 73.8% |
| edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
| Sileon (OM:SILEON) | 20.3% | 109.3% |
| KebNi (OM:KEBNI B) | 37.8% | 90.4% |
| Yubico (OM:YUBICO) | 37.5% | 43.8% |
| InCoax Networks (OM:INCOAX) | 18.1% | 104.9% |
| BioArctic (OM:BIOA B) | 34% | 50.9% |
| Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
| SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
We're going to check out a few of the best picks from our screener tool.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders in Sweden, with a market capitalization of SEK 20.85 billion.
Operations: The company generates SEK 252.21 million from its biotechnology segment.
Insider Ownership: 34%
Earnings Growth Forecast: 50.9% p.a.
BioArctic, a Swedish biopharmaceutical company, is poised for significant growth with expected revenue increases of 40.8% per year and forecasted profitability within three years. Despite trading at 66.9% below its estimated fair value, insider transactions have not shown substantial buying in recent months. Recent approvals in South Korea for its Alzheimer's treatment, Leqembi?, and ongoing collaborations with Eisai Co., Ltd., highlight its strategic advancements in neurodegenerative diseases.
Pandox
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Pandox AB is a global hotel property company that owns, develops, and leases hotel properties, with a market capitalization of approximately SEK 38.33 billion.
Operations: The company generates its revenue primarily through two segments: own operation (SEK 3.27 billion) and rental agreements (SEK 3.82 billion).
Insider Ownership: 12.3%
Earnings Growth Forecast: 27.7% p.a.
Pandox AB, a Swedish hotel property company, has shown robust financial performance with recent quarterly earnings significantly surpassing previous figures. Despite a lower net profit margin compared to last year, the company's revenue and earnings growth are outpacing the broader Swedish market. However, challenges include a low forecasted return on equity and insufficient coverage of dividends and interest payments by earnings. Insider trading activity remains minimal over the past three months, indicating stable insider confidence in the company’s trajectory.